GlaxoSmithKline PLC — Director's Dealing 2015

Apr 14, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1361K

GlaxoSmithKline PLC

14 April 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 13 April 2015, of changes in the interests of the following Directors and Persons Discharging Managerial Responsibility, following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs), at a price of 1591.00 pence per Ordinary Share and $47.41 per ADS, following the re-investment of dividends paid on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.

Director/PDMR	Number of Ordinary Shares acquired under the personal contribution element of the plan	Number of Ordinary Shares acquired under the matching element of the plan (GSK contribution)
Sir Andrew Witty	1,803	1,803
Mr S Dingemans	687	687
Mr R G Connor	358	358
Mr N Hirons	77	77
Mr S A Hussain	307	307
Mr D S Redfern	384	384
Ms C Thomas	264	264
Mr P C Thomson	129	129
Dr P J T Vallance	922	922
Ms E Walmsley	542	542

Director/PDMR	Number of ADSs acquired under the personal contribution element of the plan	Number of ADSs acquired  under the matching element of the plan (GSK contribution)
Dr M M Slaoui	713	713
Mr W C Louv	183	183
Mr D E Troy	301	301

V A Whyte

Company Secretary

14 April 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSVZLBFEZFXBBF